EnDaceA.com

About EnDaceA.com

Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and Gram-negative septicemia (endotoxemia), as well as an assay for endotoxin.



Retrieved from "http://aboutus.com/index.php?title=EnDaceA.com&oldid=35070193"